TOUCH-TO-TEST TECHNOLOGY Trademark

Trademark Overview

On Tuesday, August 10, 2021, a trademark application was filed for TOUCH-TO-TEST TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the TOUCH-TO-TEST TECHNOLOGY trademark a serial number of 90874962. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, October 14, 2025. This trademark is owned by NOWDiagnostics, Inc.. The TOUCH-TO-TEST TECHNOLOGY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes in the field of human autoimmune and infectious diseases
touch-to-test technology

General Information

Serial Number90874962
Word MarkTOUCH-TO-TEST TECHNOLOGY
Filing DateTuesday, August 10, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2023

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes in the field of human autoimmune and infectious diseases
NOT AVAILABLE"TECHNOLOGY"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOWDiagnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSpringdale, AR 72764
Party NameNOWDiagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSpringdale, AR 72764

Trademark Events

Event DateEvent Description
Monday, May 16, 2022NON-FINAL ACTION WRITTEN
Friday, August 13, 2021NEW APPLICATION ENTERED
Friday, October 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 10, 2022ASSIGNED TO EXAMINER
Monday, May 16, 2022NON-FINAL ACTION E-MAILED
Monday, May 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 17, 2022FINAL REFUSAL WRITTEN
Monday, October 17, 2022FINAL REFUSAL E-MAILED
Monday, October 17, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 16, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 17, 2023ASSIGNED TO LIE
Wednesday, January 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 18, 2023SOU EXTENSION 1 FILED
Wednesday, October 18, 2023SOU EXTENSION 1 GRANTED
Friday, October 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 18, 2024SOU EXTENSION 2 FILED
Thursday, April 18, 2024SOU EXTENSION 2 GRANTED
Friday, October 18, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 14, 2025ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 14, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, October 18, 2024SOU EXTENSION 3 GRANTED
Friday, October 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2024SOU EXTENSION 3 FILED

Related Keywords

technology test touch human autoimmune infectious diseases field purposes testing diagnostic treatment medical